|Home | About | Journals | Submit | Contact Us | Français|
Ozone (O3) is a strong oxidant in air pollution that has harmful effects on airways and exacerbates respiratory disorders. The transcription factor Nrf2 protects airways from oxidative stress through antioxidant response element-bearing defense gene induction. The present study was designed to determine the role of Nrf2 in airway toxicity caused by inhaled O3 in mice. For this purpose, Nrf2-deficient (Nrf2−/−) and wild-type (Nrf2+/+) mice received acute and subacute exposures to O3. Lung injury was determined by bronchoalveolar lavage and histopathologic analyses. Oxidation markers and mucus hypersecretion were determined by ELISA, and Nrf2 and its downstream effectors were determined by RT-PCR and/or Western blotting. Acute and sub-acute O3 exposures heightened pulmonary inflammation, edema, and cell death more severely in Nrf2−/− mice than in Nrf2+/+ mice. O3 caused bronchiolar and terminal bronchiolar proliferation in both genotypes of mice, while the intensity of compensatory epithelial proliferation, bronchial mucous cell hyperplasia, and mucus hypersecretion was greater in Nrf2−/− mice than in Nrf2+/+ mice. Relative to Nrf2+/+, O3 augmented lung protein and lipid oxidation more highly in Nrf2−/− mice. Results suggest that Nrf2 deficiency exacerbates oxidative stress and airway injury caused by the environmental pollutant O3.
Ozone (O3) is a highly reactive gaseous oxidant air pollutant. Elevated levels of ambient O3 have been associated with increased hospital visits and respiratory symptoms including chest discomfort, breathing difficulties, coughing, and lung function decrement [1, 2]. Moreover, subjects with preexisting asthma and rhinitis are known to be particularly vulnerable to O3 and are at risk of exacerbations . Controlled O3 exposure studies in healthy volunteers found oxidant generation and temporal antioxidant depletion in fluid lining compartments of the airways or sputum . Inhaled O3 in experimental animal models causes airway inflammation and hyperresponsiveness, reactive oxygen species (ROS) production, mucus overproduction, and epithelial damage and compensatory proliferation predominantly in ciliated cells of the upper respiratory tract and Clara cells in terminal bronchioles. Long-term exposure of O3 may cause lung tumors in certain strains of mice .
Many studies have investigated the roles of inflammatory mediators in the pathogenic airway response to O3. Infiltration of neutrophils into the interstitium and airways contributes to O3-induced nasal mucous cell metaplasia and airway hyperreactivity [6, 7], although some studies demonstrated uncoupling of airway inflammation and hyperreactivity [8, 9]. Tumor-necrosis-factor- (TNF-) α, a susceptibility gene for O3 toxicity in mice , has a significant role in O3-induced inflammation and airway hyperreactivity in rodent lungs mediated through nuclear factor-κB and activator protein-1 [10–13]. Toll-like receptor 4 and inflammasome proteins (e.g., Nlrp3) also contribute to O3-induced airway hyperpermeability and hyperreactivity, respectively, in mice [14–16].
O3 is thought to initiate toxicity by oxidation of biomolecules including proteins and lipids in epithelial lining fluid (ELF) of the airways, which is believed to activate signaling cascades and initiate inflammatory sequelae . Nonenzymatic antioxidants in the ELF that protect membranes and macromolecules include uric acid, ascorbic acid, tocopherol, and glutathione (GSH), and their protective roles against O3 have been investigated chemically  and biologically [19, 20]. Enzymatic antioxidant and defense proteins bearing cis-acting antioxidant response elements (AREs) for the transcription factor nuclear NF-E2-related factor 2 (Nfe2l2, Nrf2) binding are particularly abundant in cellular and extracellular compartments of airway tissues. It has been determined that O3 causes increases of ARE-responsive antioxidants including direct, scavenging enzymes (e.g., superoxide dismutases (SODs)) and indirect, defense enzymes (e.g., glutathione-S-transferase (GST), heme oxygenase-1 (HO-1)) in the lung [17, 21]. More recent studies indicated that O3 increased pulmonary Nrf2 in vivo or in vitro [22–24]. Protective roles of Nrf2 and ARE-responsive antioxidant effectors against O3 toxicity are thus implicit while their functions are not well understood.
The current study was designed to test the hypothesis that Nrf2 protects the lung against the pathogenesis of O3-induced injury in the mouse. For this purpose, mice deficient in Nrf2 (Nrf2−/−) and their wild-type controls (Nrf2+/+) were exposed to O3 using two models. Acute exposure (3hr) to 2 parts per million (ppm) O3 caused airway inflammation characterized by neutrophil inflammation that peaks approximately 6hr after exposure and induced airways hyperreactivity approximately 24hr after exposure. Subacute exposure (24–72hr) to 0.3ppm O3 caused airways inflammation. Use of both exposure models enabled us to evaluate the role of Nrf2 for multiple O3-related phenotypes by comparing responses between two genotypes.
Breeding colonies of Nrf2+/+ and Nrf2−/− mice  were backcrossed to ICR (Taconic, Hudson, NY, USA) as previously published  and maintained in the National Institute of Environmental Health Sciences (NIEHS) animal facility. Mice were provided with modified AIN-76A diet and water ad libitum.
After acclimation, mice were placed in individual stainless-steel wire cages within a whole-body inhalation chamber (Hazelton 1000; Lab Products, Maywood, NJ, USA) equipped with a charcoal and high-efficiency particulate air-filtered air supply. Mice had free access to water and food. For the sub-acute model, mice were exposed continuously to 0.3ppm O3 for 6, 24, 48, or 72hr. For the acute model, mice were exposed continuously to 2ppm O3 for 3hr and recovered in room air for 3, 6, or 24hr. O3 was generated from ultrahigh purity air (<1ppm total hydrocarbons; National Welders Inc., Raleigh, NC, USA) using a silent arc discharge O3 generator (Model L-11, Pacific Ozone Technology, Benicia, CA, USA). Constant chamber air temperature (72 ± 3°F) and relative humidity (50 ± 15%) were maintained. O3 concentration was monitored continually (Dasibi model 1008-PC, Dasibi Environmental Corp.). Parallel exposure to filtered air was done in a separate chamber for the same duration. Immediately following each exposure, mice were euthanized by sodium pentobarbital overdose (104mg/Kg). All animal use was approved by the NIEHS Animal Care and Use Committee.
At the end of designated exposure duration, mice were anesthetized with urethane (1.5g/kg in 0.125μg/μLPBS, i.p.), placed on a temperature controlled heating pad, and connected to an EKG monitor. A tracheal cannula was surgically inserted and attached to a small animal ventilator equipped with a nebulizer. After loss of responses to pain stimulus (foot pinch), mice were paralyzed with pancuronium bromide injection (0.8mg/kg as 0.08mg/mLPBS) and subjected to a deep lung inflation. Lung function was measured using a computer controlled flow-type body plethysmograph system (FlexiVent; SciReq Inc., Montreal, QC, Canada). Mice were ventilated at a respiratory rate of 150 breaths/min and tidal volume of 10mL/kg against a positive end expiratory pressure of 3cm H2O. Following baseline resistance measurements, mice were challenged with increasing doses of acetylcholine aerosol (6.25, 12.5, or 25mg/mL). Lung function parameters were acquired by fitting pressure and volume data to the single compartment model and the constant-phase model measuring parameters including resistance of the whole respiratory system as described by the manufacturer. From the plot of resistance against acetylcholine concentration, area under the curve (AUC) of resistance was calculated.
Right lungs from each mouse were lavaged in situ with HBSS, and BAL returns were analyzed for total protein content and cell differentials as described previously .
Left lung tissues from each mouse were inflated gently with 10% neutrally buffered formalin, fixed under constant pressure for 30min, and proximal (around generation 5) and distal (approximately generation 11) levels of the main axial airway were sectioned for paraffin embedding. Tissue sections (5μm thick) were stained with H&E and AB/PAS.
Secreted mucin 5, subtypes A and C (Muc5AC) protein was determined with adaptation of a published method [27, 28]. Briefly, an aliquot of BAL fluid (20μL) was loaded in each well of an ELISA plate containing a polyclonal anti-Muc5AC capture antibody (1:40 dilution; sc-19603, Santa Cruz Biotechnology Inc., Santa Cruz, CA, USA) in pH 9.5 bicarbonate-carbonate coating buffer (BD OptEIA Reagent; BD Biosciences Pharmingen, San Diego, CA, USA). The plate was incubated at 48°C until the reaction was dry (>5hr). The wells were washed and blocked overnight with an assay diluent containing 10% fetal bovine serum (BD Opt EIA) at 4°C. The samples were then incubated with a 1:100 diluted biotinylated monoclonal anti-Muc5AC detection antibody (Clone 45M1; Thermo Scientific/Lab Vision Co., Fremont, CA, USA) for 1.5hr at 37°C. Following incubation with a peroxidase-conjugated secondary antibody (1:2500, goat anti-mouse-IgG-HRP), color change was developed by adding the TMB substrate solution. Optical density was measured at 450nm after the stop buffer was added.
The amount of oxidized protein was quantified in lung protein aliquots by colorimetric detection of protein carbonyls . Briefly, total lung protein samples (1μg) were adsorbed onto a 96-well plate (OxiSelect Protein Carbonyl ELISA; Cell Biolabs Inc., San Diego, CA, USA) overnight at 4°C. After derivatization of the protein carbonyls moieties by adding 2,4-dinitrophenylhydrazine (DNP), the protein samples were incubated with an anti-DNP antibody and a secondary antibody in turn following the manufacturer's instructions. The protein carbonyl contents were quantified by absorbance at 450nm using a standard curve from predetermined reduced and oxidized BSA standards. Lung lipid oxidation was determined by measuring the amount of malondialdehyde (MDA) which forms 1:2 adduct with thiobarbituric acid (TBA). Briefly, an aliquot of lung homogenates (equivalent to 50μg proteins) was incubated with TBA reactive substances (OxiSelect TBARS Assay; Cell Biolabs Inc.) at 95°C for 1hr. Color change indicating MDA-TBA adducts was measured spectrophotometrically at 532nm, and MDA was quantified using a standard curve. Total glutathione levels in airway ELF were quantified by a kinetic method in an aliquot of BAL fluid (20μL) following the manufacturer's instruction (OxiSelect Total Glutathione Assay; Cell Biolabs Inc.). Briefly, oxidized glutathione (GSSG) in the sample was reduced to GSH by adding glutathione reductase in the presence of NADPH and subsequently adding chromogen for reaction with the thiol group of GSH, which produced a colored compound that was detectable at 405nm. Total GSH concentration proportional to the rate of chromophore production was determined by comparison with the predetermined GSH standard curve.
cDNA was prepared from total lung RNA of each mouse (n = 3-4/group), and quantitative PCR was performed following a published procedure  using 240nM of primer sets specific for glutathione peroxidase 2 ((GPx2) 381 forward 5′-tgc aac cag ttc gga cat c-3′, 531 reverse 5′-agg caa aga cag gat gct c-3′), HO-1 (901 forward 5′-aga tca gca cta gct cat ccc-3′, 1074 reverse 5′-gcc agg caa gat tct ccc tta-3′), or NADP(H):quinone oxidoreductase 1 ((NQO1) 1141 forward 5′-agc gag ctg gaa aat act ct-3′, 1303 reverse 5′-ggc cat tgt tta ctt tga gc-3′) in a 7700 prism sequence detection system (Applied Biosystems, Carlsbad, CA, USA). Semiquantitative PCR was done for Nrf2 message .
Lung total proteins (50μg) isolated from RIPA homogenates were separated on appropriate percentage Tris-HCl SDS-PAGE gels (Bio-Rad Laboratories, Hercules, CA, USA) and analyzed by routine Western blotting using specific antibodies against Nrf2 (Santa Cruz Biotechnology Inc.) and pan-actin (Santa Cruz Biotechnology Inc.). Representative protein blot images from duplicates were scanned using the Bio-Rad Gel Doc system.
SigmaPlot 11.0 (Systat Software Inc., San Jose, CA, USA) was used to compare means. One-way ANOVA followed by Student-Newman-Keuls test for a posteriori comparisons was used for Nrf2 mRNA data sets. Two-way ANOVA followed by Student-Newman-Keuls test was used for other data sets. Data were expressed as group mean ± SEM. A P value less than 0.05 was considered statistically significant.
Overall, compared to acute O3 exposure, sub-acute O3 exposure caused greater pulmonary protein edema determined by total protein concentration and airway cell lysis determined by lactate dehydrogenase level by 72hr exposure. In contrast, acute O3 exposure caused more pronounced inflammatory cell influx to the airways than sub-acute exposures. The degree of airway epithelial cell exfoliation was similar in both models.
With the exception of epithelial cells, no significant differences in the mean number of cellular phenotypes were found between Nrf2−/− and Nrf2+/+ mice after air exposure. However, 0.3ppm O3 caused significant lung edema, cellular injury, and inflammatory cell influx in both genotypes of mice, which were maximal after 72hr exposure (Figure 1). Relative to Nrf2+/+ mice, significantly heightened lung cell cytotoxicity indicated by BAL lactate dehydrogenase level, edema indicated by total BAL protein concentration, and epithelial exfoliation were found in Nrf2−/− mice (Figure 1). However, no significant difference was observed in mean numbers of BAL neutrophils between the genotypes after O3 (Figure 1).
No significant differences in mean BAL phenotypes were found between Nrf2−/− and Nrf2+/+ mice after air exposure. Relative to sub-acute O3 exposure that caused mild-to-moderate BAL phenotype changes, 2ppm O3 caused acute phase inflammatory responses characterized by neutrophilic influx (Figure 2). Significantly greater mean numbers of BAL neutrophils, epithelial cells, and total protein concentration were found as early as 3hr postexposure (PE) in Nrf2−/− mice compared to Nrf2+/+ mice (Figure 2). BAL cell lysis was also significantly greater in Nrf2−/− mice than in Nrf2+/+ mice at 24hrPE (Figure 2).
Total airway response to acetylcholine indicated by AUC was measured at 24hrPE after 2ppm O3 exposure. Mice exposed to either air or O3 did not respond differently to aerosolized acetylcholine compared to vehicle (see Supplementary Figure 1 available online at http://dx.doi.org/10.1155/2013/254069). Although dose response pattern to acetylcholine was observed in AUC regardless of the genotype and exposure, genetic deletion of Nrf2 did not significantly alter airway responsiveness basally or after O3 (Supplementary Figure 1).
Compared to air exposure, 0.3ppm O3 caused mild histologic changes in Nrf2+/+ lungs characterized by thickening of epithelium lining bronchioles and terminal bronchioles indicating epithelial cell proliferation and by neutrophil influx in air spaces after 72hr (Figure 3(a)). More severe proliferation was found in Nrf2−/− mice exposed to 0.3ppm O3, which extended to alveolar epithelium in addition to terminal bronchial epithelium and coincided with inflammatory cell accumulation (Figure 3(a)). Consistent with the BAL phenotypes, 2ppm O3 caused histologically evident inflammatory cell influx to the air spaces particularly in Nrf2−/− mice from 6hrPE (Figure 3(a)). The abundance of AB/PAS-positive mucus-bearing goblet cells in main stem airway epithelium was increased in both genotypes after 0.3ppm O3, while this mucous cell hyperplasia was more manifest in Nrf2−/− mice than in Nrf2+/+ mice (Figure 3(b)). Acute O3 also caused bronchial mucous cell hyperplasia and airway mucus hypersecretion more noticeably in Nrf2−/− mice than in Nrf2+/+ mice (Figure 3(b)). As assessed by Muc5AC protein amounts in BAL fluids, mucus hypersecretion was found earlier and/or in greater amounts in Nrf2−/− mice compared to Nrf2+/+ mice after sub-acute and acute exposures (Figure 3(c)).
Significant pulmonary lipid peroxidation was found after 48hr exposure to 0.3ppm O3 and 24hrPE to 2ppm O3 in Nrf2+/+ mice (Figure 4(a)). Compared to Nrf2+/+ mice, we found significantly greater and earlier lung lipid peroxidation in Nrf2−/− mice during 0.3-ppm O3 (6hr) while O3-induced lipid oxidation status was similar between two genotypes at other time points (Figure 4(a)). Acute O3 exposure caused significantly greater lung lipid peroxidation at 24hr PE in Nrf2−/− mice than in Nrf2+/+ mice (Figure 4(a)). The kinetics of lung lipid peroxidation and protein oxidation were not the same in the two O3 exposure models (Figures 4(a) and 4(b)). Mean protein carbonyl groups were greater in Nrf2−/− mice than in Nrf2+/+ mice after air exposure (Figure 4(b)). The amount of protein carbonyl group was significantly increased over the air control after 3d exposure to 0.3-ppm O3, and the O3-induced protein oxidation was significantly greater in Nrf2−/− mice than in Nrf2+/+ mice after 2-3d exposure. The effects of 2ppm O3 on protein oxidation were found at 3hPE, and no significant effect of genotype was found (Figure 4(b)). Different from lung tissue levels , no Nrf2-dependent glutathione depletion was found in ELF of air-exposed control mice (Figure 4(c)). Total glutathiones (oxidized GSSG and reduced GSH) in BAL fluids were significantly enhanced after 6hr of 0.3-ppm O3 in both genotypes. Glutathione level in Nrf2+/+ mice remained elevated up to 72hr of 0.3ppm O3, while it significantly declined from 48hr O3 in Nrf2−/− mice (Figure 4(c)); this decline occurred simultaneously with increases in protein and lipid oxidations in these mice (Figures 4(a) and 4(b)). Acute exposure to O3 also significantly increased total BAL glutathione in Nrf2+/+ mice but not in Nrf2−/− mice (Figure 4(c)).
Compared to air-exposed controls, mRNA expression of lung Nrf2 in Nrf2+/+ mice was significantly enhanced after 6 and 24hr exposure to 0.3ppm O3 and declined thereafter (Figure 5(a)). Lung protein level of Nrf2 remained elevated after 72hr O3 (Figure 5(a)). Following acute exposure to 2ppm O3, Nrf2 message level appeared to increase relative to air-exposed mice, but these increases were not statistically significant (Figure 5(a)). Relative to air control mice, lung Nrf2 proteins also increased 3hr after exposure to 2ppm O3 (Figure 5(a)). We also characterized expression profiles of pulmonary ARE-responsive genes GPx2, HO-1, and NQO1 after O3 exposure. The kinetics of message levels for the genes were largely similar to those of Nrf2 (Figure 5(b)), with increases after 6 and 24hr exposure to 0.3ppm O3 and increases at 3 and 6hr PE to 2.0ppm O3. Nrf2-dependent differences in mean gene expression levels were found after air exposure in HO-1, after exposure to 0.3ppm O3 in GPx2 (48 and 72hr), HO-1 (6, 24, and 48hr), and NQO1 (24hr), and after exposure to 2.0ppm O3 in Gpx2 (3 and 6hrPE), HO-1 (6hrPE), and NQO1 (6hrPE) (Figure 5(b)).
Among components of ambient pollutions, O3 is one of the most intensively studied oxidants. However, despite the extensive research on health effects of exposure to O3, mechanisms of differential susceptibility among exposed humans and animals remain unclear. In the present study we found that, relative to wild-type mice, mice with targeted deletion of the transcription factor Nrf2 had greater numbers of inflammatory cells and markers of oxidative stress and diminished antioxidant capacity following exposure to 0.3 or 2.0ppm O3. These studies support the hypothesis that Nrf2 has an important role in protecting the lung against the inflammation and injury induced by exposure to O3 and may lead to means for preventing injury induced by inhaled oxidants.
High concentrations of O3 (≥2ppm) are not encountered in the outdoor environment. However, short exposures to high concentrations have been used to predict a possible human exposure during vigorous exercise at a high O3 concentration of approximately 0.4ppm . Acute exposures also provide a reproducible tool to examine molecular and cellular events underlying acute lung injury caused by oxidant overload. Sub-acute exposure (up to 72hr) to 0.3ppm O3 represents a more environmentally relevant dosing regimen and also elicits airways inflammation though airways hyperreactivity is not a strong feature of this model. Based on National Ambient Air Quality Standards for ambient O3 (8hr average 0.075ppm; details in http://www.epa.gov/air/criteria.html) and results from dosimetry studies in which rodents require 4-5-fold higher doses of O3 than humans to create an equal deposition and pulmonary inflammatory response , either level of O3 used in the current study is a reasonable exposure level which is comparable with humans exposures. Interestingly, some of the protective effects of Nrf2 were specific to the two exposure regimens. For example, significantly greater number of total cells and neutrophils were found in Nrf2−/− mice relative to Nrf2+/+ mice after acute exposure to 2ppm O3, while no genotype effects were found after exposure to 0.3ppm O3. One reason for this difference may be attributed to a difference in the magnitude of the injury induced by two concentrations of O3 in the current models. The acute exposure model elicited a larger cellular inflammatory response (e.g., 20 × 103 versus 2 × 103 neutrophils), and it is possible that the protective effect of Nrf2 may not be manifested until greater injury and subsequent sequelae initiate Nrf2 activation. Conversely, loss of Nrf2 caused increased BAL protein, epithelial cell loss, histopathological changes, and Muc5AC production in both models. The different protective effects of Nrf2 in the two models illustrate the complexity of the pulmonary response to oxidant stimuli and suggest that Nrf2 may have different protective capacities against environmental stressors that are dose-dependent.
A role for Nrf2 in response to other air pollutants has also been demonstrated. Particulate matter (PM) is known to be proinflammatory and generates ROS in airway cells and tissues, and studies have suggested a role for the Nrf2-ARE pathway in pulmonary defense against ambient PM exposures. For example, diesel exhaust particles (DEP) increased Nrf2 levels and ARE responses in airway epithelial cells . Nrf2-deficient mice were significantly more susceptible to lung DNA adduct formation and allergic airway inflammation induced by DEP, compared to similarly exposed wild-type mice [33, 34]. Chronic exposure to nanosized PM also enhanced Nrf2 and ARE-responsive detoxifying enzymes in the lung . Williams et al.  demonstrated that dendritic cells from Nrf2−/− mice heightened Th2-type allergic responses including expression of surface antigens and production of interleukins 10 and 12 against ambient PM, compared to dendritic cells derived from wild-type mice. Supporting a role for Nrf2 in inflammatory allergic responses against airborne particles, polymorphisms in NRF2 and ARE-responsive antioxidant genes (GSTP1, SOD2) were associated with a trend toward increased risk of hospitalization during periods of high outdoor PM in an asthma/COPD cohort . In extra pulmonary tissues, potential protective roles of Nrf2-ARE in particulate toxicity have been addressed using mouse models of atherosclerosis , insulin resistance, and risk of type 2 diabetes .
Both O3 exposure regimens diminished total glutathione and increased markers of oxidant stress (oxidized proteins and lung lipid peroxidation) in the BAL fluid from Nrf2+/+ and Nrf2−/− mice. In general, these effects were greater in Nrf2−/− mice than in Nrf2+/+ mice. These results are consistent with the hypothesis that absence of Nrf2 suppresses antioxidant capacity and leads to greater O3-induced production of oxidized molecules which contributes to enhanced inflammatory response in Nrf2−/− mice compared to Nrf2+/+ mice. Although health effects of environmental O3 have been broadly examined (e.g., http://www.epa.gov/apti/ozonehealth/population.html), biochemical aspects of inhaled O3 and cellular and molecular mechanisms underlying pulmonary O3 toxicity are not fully understood. Due to limited water solubility, most of the inhaled O3 is known to reach the lower respiratory tract. O3 in the lung dissolves in the thin layer of ELF of the conducting airways, and reacts rapidly with various biomolecules, particularly those containing thiol or amine groups or unsaturated carbon-carbon bonds, and this reaction is thought to be mediated by ROS in the ELF. O3 itself or its reaction products (e.g., lipid ozonation products) react with underlying epithelial cells, immune cells, or neural receptors in the airway wall, and it may propagate inflammatory and allergic responses . O3 also causes oxidative DNA fragmentation and adduct (8-oxo-dG) formation , which could involve the weak carcinogenic response in mouse lung after chronic exposure [5, 42]. Antioxidants in cells and the lining fluid are thought to protect the epithelial barrier against O3 or its reaction products. Therefore potentially important mechanisms contributing to respiratory pathogenesis of O3 include the imbalance between ROS and antioxidant capacity, and Nrf2 may have an important role in maintaining the balance.
Results of our investigation lead to the possibility that dietary supplementation with antioxidants may prevent or suppress the toxic effects of exposure to O3. However, the effectiveness of antioxidant supplements (e.g., vitamins A, C, and E, N-acetylcysteine) remains inconclusive in human studies of O3 exposure . In laboratory rodents, supplementation with gamma-tocopherol significantly attenuated allergic responses and mucus production in upper airways . Servais et al.  found that immature (3wk old) rats were more sensitive to O3 (0.5ppm, 12hr/d, and 7d) in body weight loss and DNA adduct formation than adult (6wk old) rats, and they attributed this difference to relatively lower SOD, GPx, and catalase in the immature rats compared to the adults. Moreover, mice overexpressing Cu/Zn SOD (SOD1) were also resistant to acute O3 (0.8ppm, 3hr)-induced edema, inflammation, and lipid peroxidation in the lung . Recent studies demonstrated that ambient level of O3 increases Nrf2 and ARE responses in airway cells or in the lung [22–24], though little attention has focused on the role of Nrf2. In addition, mice genetically deficient in phase 2 detoxifying enzymes, direct Nrf2 effectors, have variable responses to O3. Enhanced inflammation, vascular permeability, and DNA adduct formation were found in the lung of metallothionein (Mt1/Mt2) null mice after sub-acute O3 (0.3ppm, 65hr) exposure . In contrast, with 70% depletion of glutathione, reduced lung injury was found in mice deficient in modifier subunit of glutamate cystein ligase (Gclm) relative to their wild-type controls . The authors suggested that compensatory magnification of antioxidant defenses such as metallothioneins, alpha-tocopherol transporter protein, and solute carrier family 23 member 2 (sodium-dependent vitamin C transporter) in Gclm−/− mice may confer increased resistance to O3-induced lung injury . Similarly, mice genetically deficient in peroxiredoxin (Prdx1) were more protected against acute O3 (2ppm, 6hr)-induced lung inflammation compared to wild-type mice, and Prx1 as a potent pro-inflammatory factor activating toll-like receptor 4/NF-κB signaling was thought to recruit the inflammatory regulators in the model . Overall, deletion of single defense enzyme may not be sufficient to affect airway pathogenesis by acute or sub-acute O3. The protective effect of Nrf2 in O3-exposed lung was noticeable in anti-inflammation and redox balance as well as protection of airway cell death and exfoliation and mucus overproduction in either or both exposure periods. Inasmuch as emerging evidence indicates that Nrf2 not only modulates antioxidant enzymes but also affects various pathways including cell cycle and immunity directly through ARE target genes or indirectly through interaction with other signaling networks [26, 49, 50], Nrf2 may exert its defensive effect against O3 not only through antioxidant defense but also through mechanisms such as activation of macrophage scavenger receptor  or inhibition of the inflammasome pathway .
Acute exposure to 2ppm O3 did not alter airways reactivity in wild-type mice, and any effect of Nrf2 deficiency on airway hyperreactivity in response to O3 could not be evaluated in the current study. It has been noted that changes in airways reactivity and inflammation/injury in response to O3 are not always codependent in rodents  or in human subjects [54, 55]. Furthermore, airways reactivity to acetylcholine is strain dependent . The background strain (ICR) of the current study may have contributed to the low acetylcholine reactivity basally and after O3 exposure, considering that ICR mice are more like Th1-responders as they lack pulmonary eosinophilia and serum IgE induction after airway viral infection , compared to Th2-responder strains such as BALB/cJ. Alternatively, as severe mucus overproduction and hyper-secretion are the key phenotypes in the O3-susceptible Nrf2−/− mice, it is also possible that airway plugging by excess mucus may hinder the access of aerosolized acetylcholine to the muscarinic receptors and interrupt the measurement of airway functions in these mice. Further investigations with targeted deletion of Nrf2 on different strain backgrounds should provide insight to the role of Nrf2 on airway reactivity.
Genetic loss of Nrf2 augmented pulmonary cellular toxicity including inflammatory cell influx, epithelial injury, and mucous cell hyperplasia leading to mucus hyper-secretion against ambient levels of O3. Heightened pulmonary oxidative stress indicated by lipid peroxidation after acute O3 exposure and protein oxidation after sub-acute O3 exposure parallel with suppressed antioxidant defense in Nrf2−/− mice relative to their wild-type controls explain the protective role of Nrf2. Results suggest that therapeutic intervention of Nrf2 inducers for respiratory disorders may protect individuals at risk to environmental oxidants.
Supplemental Figure 1 demonstrates airway responses to acetylcholine in Nrf2+/+ and Nrf2−/− mice exposed to acute O3 at 24hr PE. Total airway resistance (R, cmH2Os/mL) was measured in tracheotomized mice in response to increasing aerosolized acetylcholine concentrations (6.25-25mg/mL) using the FlexiVent system. Airway reactivity was expressed as area under the curve (AUC, cmH2Os/mL x mg/mL) for R.
The authors declare that they have no conflict of interests.
H.-Y. Cho and S. R. Kleeberger designed the research; H.-Y. Cho and W. Gladwell conducted the research, and M. Yamamoto provided the animals; H.-Y. Cho analyzed data and wrote the paper; S. R. Kleeberger edited the paper. All authors have read and approved the final paper.
This research was supported by the Intramural Research Program of the National Institute of Environmental Health Sciences (NIEHS), National Institutes of Health (NIH), Department of Health and Human Services. This research was supported by the Intramural Research Program of the NIEHS, NIH, Department of Health and Human Services. O3 exposures were conducted at Alion Science and Technology Inc. The authors thank Dr. Daniel Morgan and Mr. Herman Price for coordinating the inhalation exposures. Drs. Donald Cook and Mike Fessler of the NIEHS provided excellent critical review of the paper.